Twist Bioscience Corporation (TWST) Earnings History
Annual and quarterly earnings data from 2016 to 2025
Loading earnings history...
TWST EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
TWST Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | 50.7% | -36.2% | -20.6% |
| 2024 | 42.6% | -70.6% | -66.7% |
| 2023 | 36.6% | -88.6% | -83.5% |
| 2022 | 41.4% | -115.3% | -107.0% |
| 2021 | 39.1% | -115.4% | -114.9% |
Download Data
Export TWST earnings history in CSV or JSON format
Free sign-in required to download data
Twist Bioscience Corporation (TWST) Earnings Overview
As of May 8, 2026, Twist Bioscience Corporation (TWST) reported trailing twelve-month net income of -$81M, reflecting +63.9% year-over-year growth. The company earned $-1.32 per diluted share over the past four quarters, with a net profit margin of -20.6%.
Looking at the long-term picture, TWST's historical earnings data spans multiple years. The company achieved its highest annual net income of -$44M in fiscal 2016.
Twist Bioscience Corporation is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including ILMN ($853M net income, 19.6% margin), PACB (-$546M net income, -341.5% margin), BEAM (-$65M net income, -57.2% margin), TWST has room to improve margins relative to the peer group. Compare TWST vs ILMN →
TWST Earnings vs Peers
Earnings metrics vs comparable public companies
TWST Historical Earnings Data (2016–2025)
10 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$78M | +62.8% | -$136M | $-1.30 | -20.6% | -36.2% |
| 2024 | -$209M | -2.0% | -$221M | $-3.60 | -66.7% | -70.6% |
| 2023 | -$205M | +6.1% | -$217M | $-3.60 | -83.5% | -88.6% |
| 2022 | -$218M | -43.2% | -$235M | $-4.04 | -107.0% | -115.3% |
| 2021 | -$152M | -8.7% | -$153M | $-3.15 | -114.9% | -115.4% |
| 2020 | -$140M | -30.0% | -$140M | $-3.57 | -155.3% | -155.5% |
| 2019 | -$108M | -51.1% | -$109M | $-3.92 | -198.0% | -200.1% |
| 2018 | -$71M | -20.1% | -$71M | $-2.68 | -280.2% | -277.5% |
| 2017 | -$59M | -34.5% | -$58M | $-3.16 | -550.8% | -543.2% |
| 2016 | -$44M | - | -$44M | $-2.35 | -1943.1% | -1924.0% |
See TWST's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs TWST Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare TWST vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonTWST — Frequently Asked Questions
Quick answers to the most common questions about buying TWST stock.
Is TWST growing earnings?
TWST EPS is $-1.32, with earnings growth accelerating to +63.9%. This exceeds the 5-year CAGR of N/A. TTM net income reached $-81M.
What are TWST's profit margins?
Twist Bioscience Corporation net margin is -20.6%, with operating margin at -36.2%. Below-average margins reflect competitive or cost pressures.
How consistent are TWST's earnings?
TWST earnings data spans 2016-2025. The accelerating earnings trend is +63.9% YoY. Historical data enables comparison across business cycles.